Larimar Therapeutics Inc. (LRMR)
NASDAQ: LRMRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.75 0.00%
LRMR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $285.68M
- EPS (TTM)
- -$1.99
- Dividend yield
- None
- 52-week range
- 2.72 – 6.42
- Day range
- 2.72 – 2.84
- Volume / Avg
- 717.37K / 1.33M
- Beta
- —
- Shares outstanding
- 103.88M
- Next earnings
- Nov 4, 2026
52-week range
LRMR stock today
On Oct 7, LRMR ended the session at $2.75, shedding $0.03 (1.08%), versus the S&P 500's 0.22% decline. Shares are 57.2% below their 52-week high of $6.42, set on Feb 25, 2026 and 1.3% above the 52-week low of $2.72, near the bottom of the past year's range. LRMR is down 27.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 41.7%.
Larimar Therapeutics has posted a net loss over the last twelve months (EPS of -$1.99), so its P/E ratio is not meaningful. Larimar Therapeutics's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Larimar Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2014
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.35
Larimar Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BIOABioAge Labs Inc. | 6.26 | -0.48% | $287.31M | vs LRMR |
| ABEOAbeona Therapeutics Inc. | 5.08 | +1.40% | $290.49M | vs LRMR |
| CATXPerspective Therapeutics Inc. | 2.46 | +4.24% | $280.81M | vs LRMR |
| FULCFulcrum Therapeutics Inc. | 3.67 | -0.54% | $280.01M | vs LRMR |
| RCKTRocket Pharmaceuticals Inc. | 2.54 | +2.22% | $278.28M | vs LRMR |
| INDPIndaptus Therapeutics Inc. | 2.26 | -12.74% | $301.13M | vs LRMR |
| BBOTBridgeBio Oncology Therapeutics Inc. | 3.44 | -1.71% | $275.80M | vs LRMR |
| VNDAVanda Pharmaceuticals Inc. | 4.56 | +0.89% | $275.71M | vs LRMR |
Indexes, lists and sector
Larimar Therapeutics stock FAQ
What is Larimar Therapeutics's stock price today?
LRMR last traded at $2.75 as of Oct 7, 4:00 PM EDT, down 1.08% on the day. Prices are delayed at least 15 minutes.
When is Larimar Therapeutics's next earnings date?
Larimar Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.35.
What is the LRMR 52-week high?
The 52-week high for LRMR is $6.42 and the 52-week low is $2.72. The stock is currently 57.2% below its high.